☆ 4.7 Editorial Material

A forgotten dimension of big data in drug repositioning

EUROPEAN JOURNAL OF CANCER (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks

Shimei Qin et al.

Summary: Drug repositioning is an effective approach to develop drugs for complex diseases like cancer and network-based computational biology approaches have been successfully applied to drug repurposing. In this study, a new strategy for network-based drug repositioning against cancer was developed. By constructing a cancer-related drug similarity network and quantifying the correlation score of each drug with specific cancer, potential repositionable drugs were identified and confirmed by clinical trial articles and databases. The targets of these drugs were significantly associated with the prognosis of NSCLC and provided valuable perspective for drug repurposing in cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Oncology

A View on Drug Development for Cancer Prevention

Andrew R. Reynolds et al.

Summary: Despite limited success in cancer prevention drug development, this review explores progress made and suggests key concepts that could enhance future drug development, focusing on unmet clinical needs, patient identification, risk stratification, pharmacological intervention, clinical trials, and healthcare policy. Successfully implementing these concepts may lead to an increase in the availability of cancer prevention medicines.

CANCER DISCOVERY (2023)

Add to Collection

Review Oncology

Drug repositioning for cancer in the era of AI, big omics, and real-world data

Robert Wieder et al.

Summary: This article reviews the potential of using machine learning/artificial intelligence (ML/AI) approaches and real-world data (RWD) to overcome the limitations of clinical trials and retrospective analyses in drug repositioning. The article proposes a two-tiered filtering approach that considers drug-target binding affinity scores and real-world scenarios to identify top-ranked drugs for efficacy and safety. This approach can generate hypotheses for testing in randomized clinical trials with a high probability of success.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Add to Collection

Review Health Care Sciences & Services

Computational drug repurposing based on electronic health records: a scoping review

Nansu Zong et al.

Summary: This article evaluates the use of electronic health records (EHR) for computational drug repurposing and summarizes its contributions as well as the challenges in validation, accessibility, and understanding of EHR. The findings can assist researchers in utilizing medical data resources and developing more effective computational methods for drug repurposing.

NPJ DIGITAL MEDICINE (2022)

Add to Collection

Review Oncology

Big data in basic and translational cancer research

Peng Jiang et al.

Summary: Historically, cancer research has focused on a few essential pathways and genes, but recent advances in high-throughput technologies have led to the rapid accumulation of large-scale cancer omics data. The analysis of this "big data" requires significant computational resources and has the potential to bring new insights to cancer research. The combination of big data, bioinformatics, and artificial intelligence has already made notable advances in our understanding of cancer biology and translational research. Future progress will require collaboration among data scientists, clinicians, biologists, and policymakers.

NATURE REVIEWS CANCER (2022)

Add to Collection

Review Oncology

Turning liabilities into opportunities: Off-target based drug repurposing in cancer

Vinayak Palve et al.

Summary: Drug repurposing is an attractive complementary approach to traditional drug discovery, especially with the increasing demand for new drugs tailored to smaller patient populations. Most targeted drugs are not singularly specific, and some unintended drug off-target effects can lead to beneficial anticancer targets, contributing to novel and promising precision medicine approaches.

SEMINARS IN CANCER BIOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Artificial intelligence, machine learning, and drug repurposing in cancer

Ziaurrehman Tanoli et al.

Summary: Drug repurposing is a cost-effective strategy for drug development, and machine learning and artificial intelligence methods can help identify potential reuses systematically. The use of comprehensive target activity profiles in anticancer drug therapy can facilitate a systematic repurposing process.

EXPERT OPINION ON DRUG DISCOVERY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Drug-Repositioning Approaches Based on Medical and Life Science Databases

Yoshito Zamami et al.

Summary: Drug repositioning is a strategy that utilizes existing drugs for different diseases to reduce cost and time in drug development. Traditional method involves identifying candidate drugs through basic research, while recent approach uses information from medical and life science databases for translational research bridging the gap between basic research and clinical application.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Biochemical Research Methods

Translational medicine in the Age of Big Data

Nicholas P. Tatonetti

BRIEFINGS IN BIOINFORMATICS (2019)

Add to Collection

Article Pharmacology & Pharmacy

The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development

Joshua C. Denny et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Biochemical Research Methods

Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning

Khader Shameer et al.

BRIEFINGS IN BIOINFORMATICS (2018)

Add to Collection

Letter Biochemistry & Molecular Biology

The Drug Repurposing Hub: a next-generation drug library and information resource

Steven M. Corsello et al.

NATURE MEDICINE (2017)

Add to Collection

Review Pharmacology & Pharmacy

Drug repositioning and repurposing: terminology and definitions in literature

Joris Langedijk et al.

DRUG DISCOVERY TODAY (2015)

Add to Collection

Article Computer Science, Information Systems

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality

Hua Xu et al.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2015)

Add to Collection

Review Oncology

Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses

J. P. A. Ioannidis et al.

ANNALS OF ONCOLOGY (2014)

Add to Collection

Article Cell Biology

DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information

I. Amelio et al.

CELL DEATH & DISEASE (2014)

Add to Collection

Article Endocrinology & Metabolism

Mortality After Incident Cancer in People With and Without Type 2 Diabetes Impact of metformin on survival

Craig J. Currie et al.

DIABETES CARE (2012)

Add to Collection

Article Endocrinology & Metabolism

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16

Gijs W. D. Landman et al.

DIABETES CARE (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.